The PE Ratio as of November 2024 (TTM) for Sino Biopharmaceutical Limited (SBHMY) is 27.42

According to Sino Biopharmaceutical Limited’s latest financial reports and current stock price. The company's current PE Ratio is 27.42. This represents a change of -33.54% compared to the average of 41.26 of the last 4 quarters.

Sino Biopharmaceutical Limited (SBHMY) Historical PE Ratio (quarterly & annually)

How has SBHMY PE Ratio performed in the past?

The mean historical PE Ratio of Sino Biopharmaceutical Limited over the last ten years is 109.47. The current 27.42 PE Ratio has changed 2.40% with respect to the historical average. Over the past ten years (40 quarters), SBHMY's PE Ratio was at its highest in in the June 2022 quarter at 452.35. The PE Ratio was at its lowest in in the September 2023 quarter at 0.

Sino Biopharmaceutical Limited (SBHMY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sino Biopharmaceutical Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sino Biopharmaceutical Limited (SBHMY) Average PE Ratio

How has SBHMY PE Ratio performed in the past?

The current PE Ratio of Sino Biopharmaceutical Limited (SBHMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sino Biopharmaceutical Limited (SBHMY) PE Ratio vs. Peers

How is SBHMY’s PE Ratio compared to its peers?

Sino Biopharmaceutical Limited’s PE Ratio is greater than Institute of Biomedical Research Corp. (-0.15), greater than Defence Therapeutics Inc. (-2.24), greater than Aileron Therapeutics, Inc. (-1.83), greater than Enlivex Therapeutics Ltd. (-0.81), greater than Protagenic Therapeutics, Inc. (-0.52), greater than ZIVO Bioscience, Inc. (-5.20), greater than Cyteir Therapeutics, Inc. (-9.12), greater than Eledon Pharmaceuticals, Inc. (17.15), greater than Opthea Limited (-1.15), greater than Centessa Pharmaceuticals plc (-12.26), greater than Nuvalent, Inc. (-27.80), greater than Tarsus Pharmaceuticals, Inc. (-13.78), less than Genfit S.A. (141.32), greater than Anebulo Pharmaceuticals, Inc. (-4.78), greater than Tempest Therapeutics, Inc. (-0.66), greater than RenovoRx, Inc. (-3.51), greater than Acrivon Therapeutics, Inc. Common Stock (-3.24), greater than Acurx Pharmaceuticals, Inc. (-0.01), greater than Fennec Pharmaceuticals Inc. (-120.74), greater than XOMA Corporation (-11.81), greater than Kezar Life Sciences, Inc. (-5.71), greater than Longboard Pharmaceuticals, Inc. (-30.52), greater than Entrada Therapeutics, Inc. (13.90),

Build a custom stock screener for Sino Biopharmaceutical Limited (SBHMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sino Biopharmaceutical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sino Biopharmaceutical Limited (SBHMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sino Biopharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.